Text Size
280 studies found for:    Open Studies | "Macular Degeneration"

Modify this search | How to Use Search Results

Show Display Options
Rank Status Study
1 Recruiting An Open-label Study to Evaluate the Clinical and Economic Benefits of I-Ray in Patients With Choroidal Neovascularization Secondary to Age-related Macular Degeneration
Conditions: Age-Related Macular Degeneration;   Wet Macular Degeneration;   Macular Degeneration;   Eye Diseases;   Retinal Diseases
Intervention: Device: IRay
2 Recruiting Safety and Efficacy of Intravitreal LFG316 in Wet Age Related Macular Degeneration (AMD)
Conditions: Neovascular Age-elated Macular Degeneration (Wet AMD);   Exudative Macular Degeneration
Interventions: Drug: LFG316;   Drug: Placebo
3 Recruiting Repeated Eye Injections of Aflibercept for Treatment of Wet Age Related Macular Degeneration
Conditions: Age-Related Macular Degeneration;   Macular Degeneration
Interventions: Drug: Intravitreal Aflibercept Injection More;   Drug: Intravitreal Aflibercept Injection Less
4 Recruiting Study of Human Central Nervous System Stem Cells (HuCNS-SC) in Age-Related Macular Degeneration (AMD)
Conditions: Age Related Macular Degeneration;   Macular Degeneration;   AMD
Intervention: Drug: HuCNS-SC cells
5 Recruiting Safety and Efficacy Study of rAAV.sFlt-1 in Patients With Exudative Age-Related Macular Degeneration
Conditions: Macular Degeneration;   Age-related Maculopathies;   Age-related Maculopathy;   Maculopathies,Age-related;   Maculopathy,Age-related;   Retinal Degeneration;   Retinal Neovascularization;   Eye Diseases
Interventions: Biological: rAAV.sFlt-1;   Other: Control (ranibizumab alone)
6 Recruiting Study of Intravitreal Microplasmin in Relieving Vitreo-Macular Adhesion in Neovascular Age-related Macular Degeneration
Condition: Macular Degeneration
Interventions: Drug: Microplasmin;   Drug: Placebo control
7 Recruiting VEGF-antagonism and Endothelial Function in Age-related Macular Degeneration (AMD)
Condition: Macular Degeneration
Interventions: Drug: Ranibizumab;   Drug: Bevacizumab;   Other: No treatment
8 Unknown † Pilot Study to Evaluate the Safety and Efficacy of Treatment With ORA102 Combined With Avastin (Bevacizumab) Versus Avastin Alone, in Patients With Neovascular Age Related Macular Degeneration (AMD)
Condition: Macular Degeneration
Interventions: Drug: ORA102 and Avastin;   Drug: Avastin
9 Unknown † Safety Study for Treatment of Wet Macular Degeneration Using the TheraSight(TM) Ocular Brachytherapy System
Conditions: Macular Degeneration;   Choroidal Neovascularization
Intervention: Device: Ocular Brachytherapy
10 Unknown † Sub-tenon Triamcinolone Acetonide in Age-Related Macular Degeneration as Adjunct to Ranibizumab
Condition: Wet Macular Degeneration
Interventions: Drug: Ranibizumab;   Drug: Triamcinolone Acetonide
11 Recruiting Safety and Tolerability Study of AAV2-sFLT01 in Patients With Neovascular Age-Related Macular Degeneration (AMD)
Conditions: Macular Degeneration;   Age-Related Maculopathies;   Age-Related Maculopathy;   Maculopathies, Age-Related;   Maculopathy, Age-Related;   Retinal Degeneration;   Retinal Neovascularization;   Gene Therapy;   Therapy, Gene;   Eye Diseases
Intervention: Biological: AAV2-sFLT01
12 Recruiting Complement Factor H Haplotypes and Smoking in Age-related Macular Degeneration
Condition: Macular Degeneration
Intervention:
13 Recruiting Neovascular Age-related Macular Degeneration
Condition: Neovascular Age-related Macular Degeneration
Intervention:
14 Unknown † Subretinal Macugen® for Neovascular Age-Related Macular Degeneration
Condition: Age-related Macular Degeneration
Intervention: Drug: Pegaptanib (Macugen®)
15 Unknown † Antioxidant Systems and Age-Related Macular Degeneration
Condition: Macular Degeneration
Intervention:
16 Unknown † Copaxone in Age Related Macular Degeneration
Condition: Macular Degeneration
Intervention: Drug: Copaxone (Glatiramer acetate)
17 Not yet recruiting Intravitreal tPA and C3F8 for the Treatment of Submacular Haemorrhage as a Complication of Neovascular Age-related Macular Degeneration
Conditions: Exudative Macular Degeneration;   Retinal Hemorrhage
Interventions: Drug: Ranibizumab;   Drug: C3F8 Gas;   Drug: tPA
18 Unknown † Photodynamic Therapy Combined With Bevacizumab vs Bevacizumab Alone for Neovascular Age-Related Macular Degeneration
Condition: Neovascular Age-Related Macular Degeneration
Intervention: Drug: Bevacizumab (Avastin), Verteporfin (Visudyne)
19 Recruiting Study of the Efficacy, Safety, and Tolerability of Intravitreal Aflibercept Injection in Subjects With Exudative Macular Degeneration Previously Treated With Ranibizumab or Bevacizumab
Condition: Exudative Macular Degeneration
Intervention:
20 Not yet recruiting Proton Radiation Therapy for Macular Degeneration
Condition: Age-Related Macular Degeneration
Intervention: Radiation: Proton radiation
To Top

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
† Indicates status has not been verified in more than two years